Psychologists in Langley, WA Accepting Medicare
7 Psychologists found. Showing 1 - 7
 Dr. Ashley Lynne Crawford, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 222 Anthes Ave, Langley, WA 98260 Phone: 360-207-1865 |
Dr. Karen Vanderbilt, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 919 3rd St, Suite 101, Langley, WA 98260 Phone: 360-221-5603 Fax: 360-221-2515 |
Dr. Celia Anne Michael, PH.D. Psychologist - Health Medicare: Not Enrolled in Medicare Practice Location: 4654 Strawbridge Ln, Langley, WA 98260 Phone: 505-265-1711 |
Dr. Barbara Barry, PHD Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 919 3rd St Ste 203, Langley, WA 98260 Phone: 206-448-2107 Fax: 855-221-6770 |
Dr. Diana Lynn Chamrad, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 919 3rd St, #101, Langley, WA 98260 Phone: 360-221-7892 Fax: 360-221-2515 |
Patricia Irene Zibung Matthews, DR Psychologist Medicare: Accepting Medicare Assignments Practice Location: 919 3rd St, Suite 102, Langley, WA 98260 Phone: 360-221-4199 |
Dr. Judith Skenazy, PH.D. Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 5310 Maple Glen, Langley, WA 98260 Phone: 360-321-2810 |
News Archive
Eating Disorder Hope poise growth from Timberline Knolls sponsorship to educate sufferers
Eating Disorder Hope, a respected independent resource for individuals suffering from anorexia, bulimia, binge eating and other body image and eating disorders, is poised for growth following a significant sponsorship commitment by Timberline Knolls Residential Treatment Center.
Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients
Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.
Call for incorporation of scientific evidence into illicit drug policies
Three leading scientific and health policy organizations today launched a global drive for signatories to the Vienna Declaration, a statement seeking to improve community health and safety by calling for the incorporation of scientific evidence into illicit drug policies. Among those supporting the declaration and urging others to sign is 2008 Nobel Laureate and International AIDS Society (IAS) Governing Council member Prof. Fran-oise Barr-Sinoussi, co-discoverer of HIV.
Merck Serono starts second phase III trial of Safinamide in advanced Parkinson's
Merck Serono announced today the initiation of the SETTLE study. This study will evaluate the efficacy and safety of a dose range of safinamide (50-100 mg once daily) as add-on therapy to a stable dose of levodopa, in mid- to late-stage Parkinson's disease patients with motor fluctuations compared to placebo.
Report examines how health care reform affects personal costs, coverage, quality of service
Although most people's knowledge of the new health care law is limited, their opinion on how it will affect their health care depends on what type of private health insurance plan they currently have and their political affiliation, according to a recent report issued today by the nonpartisan Employee Benefit Research Institute.
› Verified 1 days ago
Clinical Social Workers
Counselors
Psychologists
Dentists
Occupational Therapists
Pharmacists